KOSPIElectronic Components192650

Dreamtech

₩9,400▲ 3.18%2026-10-02 close
Market Cap
₩618B
Turnover
₩11.4B
Volume
1.2M
Shares out.
65.9M
PER
—
PBR
1.1×
EPS
-₩145
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q3–2026Q2) · Dividend yield is based on ₩0 per share · Prices as of the 2026-10-02 close

01

Report overview

Between New Growth Bets and Earnings Volatility

While new businesses such as India-based memory modules and medical devices draw attention, recent quarterly results have shown large swings due to smartphone end-market weakness and equity-method losses from affiliates.

  1. 1

    2025 consolidated revenue rose year-on-year to KRW 1,230.6 billion, but net income attributable to owners nearly vanished at around KRW 0.09 billion.

  2. 2

    Both Q1 and Q2 2026 posted net losses attributable to owners (about -KRW 6.3 billion and -KRW 5.5 billion respectively), leaving the trailing four-quarter sum in a net loss position.

  3. 3

    The India subsidiary's memory module business (RDIMM/UDIMM/SODIMM) is cited as a new growth pillar, with some brokerage reports expecting full-scale mass production around the end of Q3 2026.

  4. 4

    The Biometrics/Healthcare (BHC) and camera module (CCM) segments remain sensitive to the smartphone demand cycle due to heavy reliance on major customers such as Samsung Electronics.

  5. 5

    The debt-to-equity ratio has climbed from 56.6% in 2023 to 78.3% in 2025, indicating rising financial leverage.

02

Business structure

Founded in 1998 and listed on the KOSPI in 2019, Dreamtech is an electronic component manufacturer organized into three segments: IT & Mobile Communications (IMC), Biometrics, Healthcare & Convergence (BHC), and Compact Camera Module (CCM).

The IMC segment develops and supplies sub-PBA modules and flexible OLED display panel modules for smartphones and wearables, with a revenue mix as of Q3 2024 estimated at IMC 40.4%, BHC 20.3%, and CCM 39.3%.

The BHC segment covers fingerprint sensor modules and medical devices such as wireless biosensors that transmit ECG, heart rate, respiration, and temperature data to hospital central monitoring stations, sold across the United States, Europe, and India.

The CCM segment operates through subsidiary Namuga, acquired in 2020, spanning 2D smartphone camera modules and 3D Time-of-Flight modules tied to 5G adoption.

Samsung Electronics is the company's primary customer, supplying smartphone component modules to most models, with fingerprint sensors reportedly holding around a 30% share concentrated in foldable and mid-range devices.

Production is largely handled through the company's Vietnam-based subsidiary, with diversified raw material sourcing intended to mitigate supply chain risk.

More recently, the India subsidiary has entered the semiconductor memory module business (server RDIMM, desktop UDIMM, notebook SODIMM) to diversify applications, alongside continued healthcare expansion through medical device affiliate Cardiac Insight.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q2₩291.4B₩8.8B3.0%
2025Q3₩322.5B₩10.6B3.3%
2025Q4₩275.5B₩2.1B0.7%
2026Q1₩260.7B₩400M0.2%
2026Q2₩257.3B₩100M0.0%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩1.4T₩96.7B₩85B7.1%20.7%64.5%
2023₩1T₩34B₩15.3B3.3%3.7%56.6%
2024₩1.2T₩23.6B₩3.9B2.0%1.0%76.3%
2025₩1.2T₩31.4B₩92,224,3382.5%0.0%78.3%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-08-22

04

Earnings analysis

Annual results peaked in 2022 with revenue of KRW 1,368.6 billion, operating profit of KRW 96.7 billion (7.1% operating margin), and net income attributable to owners of KRW 85.0 billion, before revenue fell to KRW 1,030.4 billion in 2023 with operating margin declining to 3.3% and owner net income shrinking to KRW 15.3 billion.

In 2024, revenue rebounded to KRW 1,172.7 billion, yet operating margin fell further to 2.0% and owner net income dropped to KRW 3.9 billion.

In 2025, both revenue (KRW 1,230.6 billion) and operating margin (2.5%, operating profit KRW 31.4 billion) improved, but owner net income nearly disappeared at roughly KRW 0.09 billion, suggesting losses related to affiliates and subsidiaries heavily eroded the bottom line attributable to controlling shareholders.

The quarterly pattern shows even greater volatility: after a net loss of KRW 3.7 billion in Q2 2025, the company returned to profit with KRW 1.1 billion in Q3 and KRW 1.2 billion in Q4, only to swing back into losses of KRW 6.3 billion in Q1 2026 and KRW 5.5 billion in Q2 2026.

As a result, the trailing four-quarter sum (Q3 2025 through Q2 2026) of owner net income stands at a loss of roughly KRW 9.5 billion.

Operating profit also contracted sharply, from KRW 10.6 billion in Q3 2025 to just KRW 0.4 billion and KRW 0.1 billion in Q1 and Q2 2026 respectively, pointing to a slowdown in core business profitability.

Notably, operating cash flow rose to KRW 95.9 billion in 2025 from KRW 44.3 billion in 2024, contrasting with the weak reported earnings and indicating cash generation held up better than accounting profit.

05

Industry analysis

Dreamtech's end markets are heavily dependent on smartphone and wearable device demand, meaning results hinge on the product launch schedules and inventory policies of a small number of major customers such as Samsung Electronics.

The roughly 20% year-on-year decline in Q1 2026 IMC segment revenue appears to reflect a high comparison base from the prior-year period, when customers had built up inventory ahead of anticipated U.S. tariff implementation.

More recently, a sharp rise in memory prices has reportedly increased pressure to cut unit prices on non-memory smartphone components, which could add further margin pressure for component suppliers.

The camera module (CCM) segment benefits from a structural growth driver in expanding 3D Time-of-Flight camera adoption tied to 5G proliferation, though the highly competitive smartphone camera market also carries persistent pricing pressure.

The medical device (BHC) segment enjoys a favorable backdrop of growing demand for remote hospital monitoring via wireless biosensors, but delayed orders and losses at affiliates including Cardiac Insight continue to weigh on consolidated earnings.

The newly entered memory module business resulted from selection as an India-based supplier under a domestic memory customer's supply chain diversification strategy, placing the company at an early stage of scaling within a broadly favorable global data center and server demand environment.

06

Outlook

The India subsidiary has reportedly completed initial mass production runs for server RDIMM, desktop UDIMM, and notebook SODIMM products for a major customer, and is said to be preparing to expand volumes through diversification of final delivery destinations.

Some brokerage reports from around June 2026 projected full-scale mass production by the end of Q3 2026 and annual production capacity exceeding KRW 200 billion at full utilization, though these are forecasts requiring confirmation through future disclosures and actual results.

A brokerage report from January 2026 also raised the possibility of entering the SSD market in the second half of 2026, a product category cited as more profitable than DIMM, though given the time elapsed since that report, actual entry requires further confirmation.

Shinhan Investment Corp stated in a June 23, 2026 report that it expects growth in the semiconductor module and medical device segments in the second half. Kiwoom Securities, in a June 5, 2026 report, similarly projected a second-half rebound, citing improving visibility on memory module progress.

On the medical device side, past brokerage reports have referenced potential large-scale orders tied to an India government tender for wireless biosensors, though the current status requires updated confirmation.

Overall, the company's medium-term narrative appears to hinge on maintaining stable performance in existing smartphone component businesses while expanding revenue contribution from the India memory module and medical device new businesses.

07

Valuation

PER
—
PBR
1.1×
ROE
-2.6%
EPS
-₩145
BPS
₩5,511
Dividend per share
₩0

The current share price appears to trade near or modestly above historical net asset value, a level that is not in an extreme premium or discount zone.

However, because the trailing four-quarter sum shows a net loss attributable to owners, traditional earnings-based multiple comparisons carry limited meaning at this juncture.

Historically, the stock's trading multiples have swung widely alongside year-to-year swings in profitability, making it difficult to treat any single-period multiple as a fixed benchmark.

Based on recent disclosures, the company does not appear to have paid a dividend, which limits the investment case built around dividend yield. On the balance sheet side, it is worth noting that the debt-to-equity ratio rose from 56.6% in 2023 to 78.3% in 2025.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-08-22

08

Bull factors

Expansion of the India Memory Module Business

The India subsidiary has completed initial mass production of server, desktop, and notebook memory modules, with some brokerages estimating annual production capacity above KRW 200 billion at full utilization.

If volumes successfully scale and facility audits by North American big tech customers are passed, direct supply channels to North America have also been mentioned as a possibility. This could diversify the revenue base beyond the traditional smartphone component-centric structure.

Structural Demand in the Medical Device Segment

Wireless biosensors are sold across multiple regions including the United States, Europe, and India, riding a structural trend of expanding demand for remote hospital monitoring. Product diversification, including arrhythmia diagnosis wearable patches, has also progressed, reducing reliance on any single product.

While affiliate losses persist, underlying revenue is anchored to the long-term trend of digital healthcare transition in hospitals.

Stable Cash Generation

Operating cash flow in 2025 rose sharply to KRW 95.9 billion from KRW 44.3 billion in 2024. This contrasts with the modest owner net income reported on the income statement, suggesting core cash generation held up once the effects of depreciation, inventory, and affiliate income/losses are excluded. Stable cash flow provides a foundation to internally support new investments such as the India plant.

09

Bear factors

Consecutive Recent Quarterly Net Losses

Both Q1 and Q2 2026 posted net losses attributable to owners, and the trailing four-quarter sum also remains in loss territory. Operating profit likewise contracted sharply from KRW 10.6 billion in Q3 2025 to just KRW 0.1 billion in Q2 2026, clearly showing weakening core profitability. This earnings volatility could persist until new business contributions become substantial.

Customer Concentration Risk

Revenue from smartphone component modules and fingerprint sensors relies heavily on a small number of customers such as Samsung Electronics, making results sensitive to changes in that customer's new product launch schedule or inventory policy.

The sharp decline in Q1 2026 IMC segment revenue is understood to partly reflect a high comparison base from prior-year tariff-related pre-buying. This customer concentration structure is likely to persist until new businesses grow sufficiently.

Affiliate Losses and Rising Financial Leverage

Delayed orders and losses at affiliates including medical device subsidiary Cardiac Insight are understood to continue eroding net income attributable to owners. At the same time, the debt-to-equity ratio has risen from 56.6% in 2023 to 78.3% in 2025, indicating rising financial leverage.

It is worth noting that this earnings pressure and balance sheet strain are occurring concurrently as new business investment continues.

10

Risk factors

End-Market Cycle Risk

Smartphone and wearable demand depends on the economic cycle and new product launch timing, and changes in major customers' inventory policies can significantly sway specific quarterly results.

Pre-buying and inventory adjustment effects tied to tariff and trade issues also distort comparison bases, increasing quarter-to-quarter volatility. Pricing pressure on non-memory components stemming from rising memory prices could also weigh on margins.

New Business Execution Risk

The India memory module business is understood to have required a longer mass production preparation period than originally expected, and there is a possibility that customer approval and volume expansion timelines could be further delayed.

The success of future events such as SSD market entry and facility audits by North American big tech customers has not yet been confirmed. Expectations of large medical device orders also require confirmation of actual contract signing.

Financial and Earnings Volatility

Net income attributable to owners has historically been sensitive to swings in affiliate and subsidiary earnings, and similar volatility could recur going forward. If rising debt levels coincide with continued new business investment burdens, financial flexibility could be reduced.

The difficulty in gauging the timing of a return to profit after consecutive quarterly net losses is also a source of uncertainty.

11

What to watch next

  1. Mid-November 2026 (tentative)

    Check the Q3 2026 earnings release for whether memory module revenue contribution materializes and whether IMC/BHC segment margins recover.

  2. End of Q3 2026

    Verify whether the tentative timeline for full-scale India memory module mass production cited by some brokerages is actually met, and monitor progress in expanding server RDIMM and other volumes.

  3. During the second half of 2026

    Confirm whether SSD market entry (per a tentative January 2026 brokerage forecast) proceeds, and check the outcome of facility audits by North American big tech customers at the India plant.

  4. Upcoming disclosure/IR schedule

    Monitor disclosures on order and loss trends at affiliates such as medical device subsidiary Cardiac Insight, as well as progress on any India government-related wireless biosensor tender.

12

Overall view

Dreamtech's structure combines a traditional smartphone component business dependent on a small number of customers such as Samsung Electronics with new growth businesses in India memory modules and medical devices.

Following a peak in 2022, profits contracted through 2023-2024, and although revenue and operating margin improved in 2025, net income attributable to owners nearly vanished, followed by consecutive net losses in Q1 and Q2 2026.

The fact that the trailing four-quarter sum also remains in a net loss position indicates that recent earnings momentum has weakened.

On the other hand, operating cash flow actually improved, creating a divergence between reported earnings and cash flow, and brokerage interest in the new growth narrative—expanding India memory module production, potential SSD entry, and large medical device orders—continues.

However, most of these new business projections remain unconfirmed expectations whose actual realization requires verification through future disclosures and results. On the balance sheet side, the rising debt ratio trend should be considered alongside continued new business investment burdens.

Ultimately, the future direction of earnings appears to hinge on whether the existing smartphone component business stabilizes and on the timing of actual revenue contribution from the new businesses.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. butler.works
  2. file.alphasquare.co.kr
  3. home.imeritz.com
  4. news.nate.com
  5. investing.com
  6. invest.deepsearch.com
  7. investing.com
  8. littlebproject.com
  9. investing.com
  10. dailyinvest.kr
  11. thebell.co.kr
  12. thebell.co.kr
  13. dailyinvest.kr
  14. jobplanet.co.kr
  15. comp.fnguide.com
  16. m.irgo.co.kr
  17. catch.co.kr
  18. newspim.com

Report written 2026-09-05 · Data as of 2026-09-04

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.